Fagartikkel

• Høgestøl, Einar August; Sowa, Piotr; Holmøy, Trygve et al. (2025). Oppdaterte diagnosekriterier for multippel sklerose. (ekstern lenke)
• Hoff, Jana Midelfart; Dhayalan, Mauran; Midelfart, Anna et al. (2019). Synsproblemer ved multippel sklerose. (ekstern lenke)

Vitenskapelig artikkel

• Saksvik, Simen Berg; Rønhovde, Liv Marie; Lynum, Kristine et al. (2025). Digital cognitive behavioral therapy for insomnia compared with digital patient education about insomnia in people with multiple sclerosis in Norway: study protocol for a randomized controlled trial. (ekstern lenke)
• Gavasso, Sonia; Haugsøen, Jonas Bull; Kleftogiannis, Dimitrios et al. (2025). High-dimensional Immune Profiling Following Autologous Hematopoietic Stem Cell Transplantation in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Fossum, Maria Therese; Torgauten, Hilde Marie; Aarseth, Jan Harald et al. (2025). Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safety. (ekstern lenke)
• Gottschlich, Katharina Natalie; Zolic-Karlsson, Zinajda; Aas, Eline et al. (2024). Healthcare utilization and costs associated with autologous haematopoietic stem cell transplantation in Norwegian patients with relapsing remitting multiple sclerosis. (ekstern lenke)
• Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne et al. (2024). Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis. (ekstern lenke)
• Kvistad, Christopher Elnan; Lehmann, Anne Kristine; Stokke, Silje Agnethe et al. (2024). Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway. (ekstern lenke)
• Kråkenes, Torbjørn; Wergeland, Stig; Al-Sharabi, Niyaz Abdulbaqi Abdulmajid et al. (2023). The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination. (ekstern lenke)
• Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne et al. (2023). Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Ahmad, Intakhar; Wergeland, Stig; Oveland, Eystein et al. (2023). An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis. (ekstern lenke)
• Karlowicz, Jakob Rishovd; Klakegg, Mattias; Aarseth, Jan Harald et al. (2023). Predictors of hospitalization due to infection in rituximab-treated MS patients. (ekstern lenke)
• Stokke, Silje Agnethe; Burman, Joachim; Lehmann, Anne Kristine et al. (2022). Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT. (ekstern lenke)
• Lie, Ingrid Anne; Kerklingh, Emma; Wesnes, Kristin et al. (2022). The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis. (ekstern lenke)
• Rød, Brit Ellen; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2022). Safety of breast feeding during rituximab treatment in multiple sclerosis. (ekstern lenke)
• Lie, Ingrid Anne; Wesnes, Kristin; Kvistad, Silje Agnethe Stokke et al. (2022). The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Lie, Ingrid Anne; Kacar, Sezgi; Wesnes, Kristin et al. (2022). Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study. (ekstern lenke)
• Torgauten, Hilde Marie; Myhr, Kjell-Morten; Wergeland, Stig et al. (2021). Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study. (ekstern lenke)
• Oveland, Eystein; Ahmad, Intakhar; Lereim, Ragnhild Reehorst et al. (2021). Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis. (ekstern lenke)
• Ahmad, Intakhar; Wergeland, Stig; Oveland, Eystein et al. (2021). A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination. (ekstern lenke)
• Nystad, Agnes Elisabeth; Lereim, Ragnhild Reehorst; Wergeland, Stig et al. (2019). Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. (ekstern lenke)
• Holmøy, Trygve; Fevang, Børre; Olsen, David Benee et al. (2019). Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis. (ekstern lenke)
• Stokke, Silje Agnethe; Lehmann, Anne Kristine; Trovik, Linn et al. (2019). Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. (ekstern lenke)
• Svendsen, Bjørn; Grytten, Nina; Bø, Lars et al. (2018). The economic impact of multiple sclerosis to the patients and their families in Norway. (ekstern lenke)
• Lunde, Hanne Marie; Assmus, Jörg; Myhr, Kjell-Morten et al. (2017). Survival and cause of death in multiple sclerosis: A 60-year longitudinal population study. (ekstern lenke)
• Lunde, Hanne Marie; Torkildsen, Øivind; Bø, Lars et al. (2016). Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia. (ekstern lenke)
• Torkildsen, Øivind; Myhr, Kjell-Morten; Bø, Lars (2016). Disease-modifying treatments for multiple sclerosis – a review of approved medications. (ekstern lenke)
• Fjær, Sveinung; Bø, Lars; Myhr, Kjell-Morten et al. (2015). Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. (ekstern lenke)
• Alme, Maria Nordheim; Nystad, Agnes Elisabeth; Bø, Lars et al. (2015). Fingolimod does not enhance cerebellar remyelination in the cuprizone model. (ekstern lenke)
• Lunde, Hanne Marie; Telstad, Wenche; Grytten, Nina Agnethe et al. (2014). Employment among patients with multiple sclerosis-A population study. (ekstern lenke)
• Nystad, Agnes Elisabeth; Wergeland, Stig; Aksnes, Lage et al. (2014). Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model. (ekstern lenke)
• Fjær, Sveinung; Bø, Lars; Lundervold, Arvid et al. (2013). Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model. (ekstern lenke)
• Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2012). The cuprizone model: regional heterogeneity of pathology. (ekstern lenke)
• Lunde, Hanne Marie; Aae, Tommy Frøseth; Indrevåg, William et al. (2012). Poor Sleep in Patients with Multiple Sclerosis. (ekstern lenke)
• Myhr, Kjell-Morten; Grytten, Nina Agnethe; Torkildsen, Øivind et al. (2012). A need for national registries and international collaborative research in multiple sclerosis. (ekstern lenke)
• Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2011). Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. (ekstern lenke)
• Tallantyre, Emma C.; Bø, Lars; Al-Rawashdeh, Omar et al. (2010). Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Stansberg, Christine; Angelskår, Solveig Mjelstad et al. (2010). Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. (ekstern lenke)
• Kooi, Evert-Jan; Horssen, Jack van; Witte, Maarten et al. (2009). Abundant extracellular myelin in the meninges of patients with multiple sclerosis. (ekstern lenke)
• Gilmore, Christopher P.; Geurts, Jeroen J.G.; Evangelou, Nikos et al. (2009). Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Thorsen, Frits Alan et al. (2009). Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. (ekstern lenke)
• Witte, Maarten; Bø, Lars; Rodenburg, Richard J. et al. (2009). Enhanced number and activity of mitochondria in multiple sclerosis lesions. (ekstern lenke)
• Gilmore, Christopher P.; DeLuca, GC; Bø, Lars et al. (2009). Spinal Cord Neuronal Pathology in Multiple Sclerosis. (ekstern lenke)
• Gilmore, Christopher P.; Donaldson, I; Bø, Lars et al. (2009). Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. (ekstern lenke)
• Tallantyre, Emma C.; Bø, Lars; Al-Rawashdeh, Omar et al. (2009). Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. (ekstern lenke)
• Kooi, Evert-Jan; Geurts, Jeroen J.G.; Horssen, Jack van et al. (2009). Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Milde, Anne Marita et al. (2009). A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination. (ekstern lenke)
• Breij, Esther C.W.; Brink, Bianca P.; Veerhuis, Rob et al. (2008). Homogeneity of active demyelinating lesions in established multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Brunborg, Linn Anne Bjelland; Myhr, Kjell-Morten et al. (2008). The cuprizone model for demyelination. (ekstern lenke)
• Couturier, Nicholas; Zappulla, Jacques P.; Lauwers-Cances, Valérie et al. (2008). Mast cell transcripts are increased within and outside multiple sclerosis lesions. (ekstern lenke)
• Horssen, Jack van; Brink, Bianca P.; Vries, Helga E. de et al. (2007). The blood-brain barrier in cortical multiple sclerosis lesions. (ekstern lenke)
• Geurts, Jeroen J.G.; Bø, Lars; Bö, Lars et al. (2007). Extensive hippocampal demyelination in multiple sclerosis. (ekstern lenke)
• Bø, Lars; Geurts, Jeroen J.G.; Valk, Paul van der et al. (2007). Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. (ekstern lenke)
• Bø, Lars; Mørk, Sverre; Geurts, Jeroen J.G. et al. (2006). Grey matter pathology in multiple sclerosis. (ekstern lenke)
• Bø, Lars; Vedeler, C.; Nyland, Harald Inge et al. (2003). Intracortical demyelination in multiple sclerosis is not associated with increased lymphocyte infiltration. (ekstern lenke)
• Bø, Lars; Vedeler, C.; Nyland, Harald Inge et al. (2003). Subpial demyelination in the cerebral cortex of multiple sclerosis. (ekstern lenke)
• Romi, Fredrik; Bø, Lars; Skeie, Geir Olve et al. (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. (ekstern lenke)
• Peterson, J.W; Bø, Lars; Mørk, Sverre et al. (2002). VCAM-1-positive microglia target oligodendrycytes at the border of multiple sclerosis lesions. (ekstern lenke)
• Peterson, John W.; Bø, Lars; Mørk, Sverre et al. (2001). Transected Neurites, Apoptotic Neurons and Reduced Inflammation in Cortical MS Lesions. (ekstern lenke)
• Trapp, BD; Bø, Lars; Mørk, Sverre et al. (1999). Pathogenesis of tissue injury in MS lesions. (ekstern lenke)

Poster

• Rødal, Linn Elin; Smedal, Tori; Wergeland, Stig et al. (2025). Tidlig screening av blæredysfunksjon ved multippel sklerose - et kvalitetsforbedringsprosjekt. (ekstern lenke)
• Gavasso, Sonia; Haugsøen, Jonas Bull; Kleftogiannis, Dimitrios et al. (2024). Short-Term and Long-Term Impact of Autologous Haematopoietic Stem Cell Transplantation on Immune Profiles in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• König, Marton; Wolf, Asia-Sophia Fumika Michaela; Ravussin, Anthony et al. (2022). Immunogenicity and efficacy of mRNA-COVID-19 vaccines in people with multiple sclerosis. (ekstern lenke)
• Fjær, Sveinung; Wergeland, Stig; Bø, Lars (2014). Magnetization transfer ratio (MTR) increased unexpectedly in EAE induced mice.. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Muraro, Paolo A.; Mariottini, Alice; Greco, Raffaella et al. (2025). Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT. (ekstern lenke)
• Kråkenes, Torbjørn; Sandvik, Casper Eugen; Ytterdal, Marie et al. (2024). The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis. (ekstern lenke)
• Kvistad, Christopher Elnan; Kråkenes, Torbjørn; Gavasso, Sonia et al. (2024). Neural regeneration in the human central nervous system—from understanding the underlying mechanisms to developing treatments. Where do we stand today?. (ekstern lenke)
• Kvistad, Christopher Elnan; Kråkenes, Torbjørn; Gjengedal, Gudveig Cecilie Gjerde et al. (2022). Safety and Clinical Efficacy of Mesenchymal Stem Cell Treatment in Traumatic Spinal Cord Injury, Multiple Sclerosis and Ischemic Stroke – A Systematic Review and Meta-Analysis. (ekstern lenke)
• Lie, Ingrid Anne; Weeda, Merlin M.; Mattiesing, Rozemarijn M. et al. (2022). Relationship between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis. (ekstern lenke)
• Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold et al. (2019). B cell depletion in the treatment of multiple sclerosis. (ekstern lenke)
• Myhr, Kjell-Morten; Grytten, Nina; Torkildsen, Øivind et al. (2015). The Norwegian Multiple Sclerosis Registry and Biobank. (ekstern lenke)
• Lunde, Hanne Marie; Bjorvatn, Bjørn; Myhr, Kjell-Morten et al. (2013). Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. (ekstern lenke)
• Wergeland, Stig; Torkildsen, Øivind; Bø, Lars et al. (2012). Polyunsaturated fatty acids in multiple sclerosis therapy. (ekstern lenke)
• Bø, Lars (2009). The histopathology of grey matter demyelination in multiple sclerosis. (ekstern lenke)

Kronikk

• Torkildsen, Øivind; Rød, Brit Ellen; Bø, Lars et al. (2022). Amming og behandling av multippel sklerose. (ekstern lenke)

Doktorgradsavhandling

• Lunde, Hanne Marie Bøe; Bø, Lars (2017). Patient-centered outcomes in multiple sclerosis. Results from observational studies on sleep, employment and survival. (ekstern lenke)
• Bø, Lars (1998). Multiple sclerosis, immunopathological studies of inflammatory control nervous system demyelination. (ekstern lenke)

Leserinnlegg

• Holmøy, Trygve; Myhr, Kjell-Morten; Bø, Lars (2014). Re: Uetisk av nevrologene ikke å tilby pasienter med multippel sklerose cytostatikabehandling med autolog stamcellestøtte. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Myhr, Kjell-Morten; Torkildsen, Øivind; Bø, Lars (2014). Multippel Sklerose. (ekstern lenke)

Vitenskapelig foredrag

• Romi, Fredrik; Bø, Lars; Skeie, Geir Olve et al. (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. (ekstern lenke)
• Bø, Lars (2001). Differences in pathology between secondary and primary multiple sclerosis. (ekstern lenke)
• Bø, Lars (2001). Normal appearing cortical tissue, pathology studies. (ekstern lenke)

Faglig foredrag

• Bø, Lars (2001). Multippel sklerose: sykdomsmekanismer. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin